Akso Health Group
NASDAQ:AHG
1.23 (USD) • At close December 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2.414 | 13.182 | 6.311 | 1.755 | 11.435 | 61.331 | 107.258 | 22.921 | 11.894 | 4.646 |
| Cost of Revenue
| 2.292 | 11.913 | 5.395 | 0.545 | 4.994 | 7.397 | 8.496 | 5.149 | 2.359 | 1.606 |
| Gross Profit
| 0.122 | 1.269 | 0.916 | 1.21 | 6.441 | 53.934 | 98.762 | 17.771 | 9.535 | 3.04 |
| Gross Profit Ratio
| 0.051 | 0.096 | 0.145 | 0.69 | 0.563 | 0.879 | 0.921 | 0.775 | 0.802 | 0.654 |
| Reseach & Development Expenses
| 0 | -0 | 0.421 | 0.545 | 1.033 | 0 | 2.817 | 5.149 | 2.359 | 1.606 |
| General & Administrative Expenses
| 8.592 | 15.529 | 15.388 | 27.273 | 26.8 | 16.514 | 7.645 | 2.646 | 1.555 | 0.734 |
| Selling & Marketing Expenses
| 0.168 | 0.007 | 0.241 | 1.087 | 16.467 | 32.322 | 15.242 | 5.212 | 3.84 | 2.605 |
| SG&A
| 8.76 | 15.536 | 15.629 | 28.36 | 43.267 | 48.836 | 22.887 | 7.858 | 5.395 | 3.339 |
| Other Expenses
| 0 | 1.2 | -0.781 | -0.165 | 1.598 | 2.307 | 0.661 | 0.18 | 0.026 | -0.008 |
| Operating Expenses
| 8.76 | 15.536 | 16.05 | 28.36 | 43.267 | 48.836 | 22.887 | 7.858 | 5.395 | 3.339 |
| Operating Income
| -8.638 | -14.267 | -15.134 | -27.15 | -36.826 | 5.098 | 75.875 | 9.914 | 4.14 | -0.299 |
| Operating Income Ratio
| -3.578 | -1.082 | -2.398 | -15.471 | -3.22 | 0.083 | 0.707 | 0.433 | 0.348 | -0.064 |
| Total Other Income Expenses Net
| -0.454 | 1.2 | -0.748 | -3.92 | 1.232 | 0.381 | 0.661 | 0.18 | 0.026 | -0.008 |
| Income Before Tax
| -9.092 | -13.066 | -16.718 | -31.069 | -66.93 | 7.405 | 76.536 | 10.093 | 4.167 | -0.306 |
| Income Before Tax Ratio
| -3.766 | -0.991 | -2.649 | -17.704 | -5.853 | 0.121 | 0.714 | 0.44 | 0.35 | -0.066 |
| Income Tax Expense
| 0.025 | 0.018 | 0.131 | 0.483 | 4.269 | 1.873 | 11.026 | 1.522 | 0.628 | 0.044 |
| Net Income
| -9.459 | -13.084 | -16.85 | -31.552 | -71.198 | 5.533 | 65.482 | 8.571 | 3.538 | -0.35 |
| Net Income Ratio
| -3.918 | -0.993 | -2.67 | -17.979 | -6.226 | 0.09 | 0.611 | 0.374 | 0.297 | -0.075 |
| EPS
| -0.21 | -0.57 | -0.85 | -1.94 | -4.38 | 0.31 | 4.12 | 0.54 | 0.22 | -0.022 |
| EPS Diluted
| -0.2 | -0.57 | -0.85 | -1.94 | -4.38 | 0.31 | 4.12 | 0.54 | 0.22 | -0.022 |
| EBITDA
| -8.5 | -14.248 | -3.26 | -2.071 | -18.795 | -6.791 | 76.05 | 10.006 | 4.202 | -0.279 |
| EBITDA Ratio
| -3.521 | -0.991 | -2.519 | -15.556 | -3.03 | 0.083 | 0.707 | 0.437 | 0.353 | -0.06 |